...
首页> 外文期刊>Clinical and experimental medicine >A new protocol for the treatment of the chronic venous ulcers of the lower limb.
【24h】

A new protocol for the treatment of the chronic venous ulcers of the lower limb.

机译:一种治疗下肢慢性静脉溃疡的新方案。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Venous leg ulcer is a pathological condition afflicting prevalently elderly patients, which has been found to have a major impact on individuals' health and social aspects of quality of life. Actually, the best practice treatment is recommended to include wound dressing and multilayer compression therapy. In this study, we have tested the effectiveness and safety of Vulnamin(?), a novel dressing in the form of a metal cellulose gel containing the amino acids glycine, L: -lysine, L: -proline, L: -leucine, and hyaluronic acid, and elastic compressive bandages in the treatment of chronic venous ulcers of the lower limbs. The study has been conducted in two groups of patients, one treated with Vulnamin(?) plus Ca-alginate (ulcer duration = 25.4?±?6.2?weeks; mean baseline ulcer area?=?13.9?±?4.5?cm(2)) and a control group treated with Ca-alginate alone (ulcer duration?=?23.4?±?4.2?weeks; mean baseline ulcer area?=?15.1?±?4.7?cm(2)). Results have shown that after 70?days of treatment patients significantly ameliorate their pathological condition if they are treated with Vulnamin(?), as compared with patients treated with Ca-alginate alone. In fact, at the end of the treatment, complete healing closure was 61% in the group treated with Vulnamin(?) and, respectively, 27% in the control group. Moreover, ulcer areas showed a significant reduction in patients treated with Vulnamin(?) (mean ulcer area?=?3.04?±?0.8?cm(2)), as compared with controls (mean ulcer area?=?10.96?±?3.8?cm(2)). Overall, the results of this study indicate that Vulnamin(?) together with elastocompression is safe and more effective than standard dressing together with elastocompression in inducing a faster healing in chronic venous ulcers of the lower limb.
机译:下肢静脉溃疡是一种普遍困扰老年患者的病理性疾病,已发现它对个人的健康和生活质量的社会方面产生重大影响。实际上,建议的最佳实践疗法包括伤口敷料和多层加压疗法。在这项研究中,我们测试了Vulnamin(?)的有效性和安全性,Vulnamin(?)是一种新型敷料,其形式为包含氨基酸甘氨酸,L:-赖氨酸,L:-脯氨酸,L:-亮氨酸和透明质酸和弹性加压绷带治疗下肢慢性静脉溃疡。该研究已在两组患者中进行,一组用Vulnamin(?)加海藻酸钙治疗(溃疡持续时间= 25.4?±?6.2?周;平均基线溃疡面积?=?13.9?±?4.5?cm(2 ))和对照组单独接受海藻酸钙治疗(溃疡持续时间=?23.4?±?4.2?周;平均基线溃疡面积?=?15.1?±?4.7?cm(2))。结果表明,与单独使用海藻酸钙治疗的患者相比,使用Vulnamin(β)治疗的患者经过70天的治疗后,可显着改善其病理状况。实际上,在治疗结束时,用Vulnamin(β)治疗的组中完全治愈的关闭率为61%,而对照组则为27%。而且,与对照组相比,用Vulnamin(α)治疗的患者的溃疡面积显示出显着减少(平均溃疡面积≥3.04±±0.80.8cm(2))(相对于平均溃疡面积≥10.96±±0.2)。 3.8?cm(2))。总体而言,这项研究的结果表明,Vulnamin(?)联合弹力加压治疗比下一次常规敷料和弹力加压治疗更安全,更有效地诱导下肢慢性静脉溃疡的更快愈合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号